We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Sensory Shoe Insoles Help Prevent Diabetic Foot Ulcers

By HospiMedica International staff writers
Posted on 16 Dec 2019
Print article
Image: Sensory insoles can monitor developing diabetic foot ulcers (Photo courtesy of Orpyx)
Image: Sensory insoles can monitor developing diabetic foot ulcers (Photo courtesy of Orpyx)
Novel insoles assist management and prevention of diabetic foot ulcers (DFUs) through advanced foot sensor technology and real-time analytics.

The Orpyx (Calgary, Canada) SI Sensory Insoles with remote patient monitoring are designed to prevent DFUs and other neuropathy-related ulcers in the soles of the feet by monitoring pressure, temperature, and movement, and providing the wearer with real-time audiovisual alerts of pending high-pressure areas that may lead to tissue breakdown. Each set of insoles are custom made and designed to effortlessly capture plantar pressure, temperature, and movement data throughout the day. Magnetic charging USB cables and an instruction manual are included with each pair of insoles.

Through a cloud-based dashboard, healthcare providers can monitor real-world data and identify trends to proactively make treatment decisions in order to keep their patients' feet healthy. In clinical studies, when compared to standard of care, Orpyx SI technology reduced DFU recurrence by up to 86% for people with diabetic peripheral neuropathy and a previous DFU. The technology can also be used to access clinical-grade plantar pressure data for health and human performance applications in the fields of sports medicine, therapeutic applications, and footwear design.

“It is our mission to eliminate preventable DFUs; current treatments are not enough. One in four people suffering from diabetes will develop a foot ulcer, and after the ulcer has healed, 40% of those will recur within the first year,” said Breanne Everett, MD, CEO of Orpyx and co-inventor of the insoles. “Once a person develops a DFU, the 5-year mortality rate is almost 50%, higher than leukemia, colon cancer, and breast cancer. In my clinical practice, I saw the physical and emotional toll DFUs had on our patients and their families. If we can prevent DFUs from recurring, we can greatly improve peoples' lives while avoiding costs.”

Diabetes patients often suffer from nerve and circulation problems in the feet, which reduce their perception of pain. The nerve pathways that ensure that weight is automatically transferred from one foot to the other during prolonged standing are disrupted, and as a result, diabetics do not notice that their toes, heels, or the balls of their feet are too heavily loaded. The foot receives no relief, and pressure sores, DFUs, and infections may go unnoticed. Serious cases may even lead to amputation.

Related Links:
Orpyx

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Washer Disinfector
TIVA 10-M

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.